Abstract:Abstract Background Neuronal accumulation of misfolded microtubule-associated protein tau is a hallmark of neuropathology in Alzheimer’s disease, frontotemporal dementia, and other tauopathies, and has been a therapeutic target. Microglia can spread tau pathology by secreting tau-containing exosomes, although the specific molecular target is yet to be identified for the therapeutic intervention. P2X purinoceptor 7 (P2RX7) is an ATP-gated cation channel, enriched in microglia and triggers exosome secretion. The purpose of the study is to examine the therapeutic effect of an orally applicable, CNS-penetrant P2RX7 specific inhibitor on the early disease stage of a tauopathy mouse model. Methods Three-months-old P301S tau mice were treated with P2RX7-specific inhibitor GSK1482160 or vehicle for 30 days, followed by behavioral, biochemical and immunohistochemical assessment. GSK1482160 was also tested for exosome secretion from primary cultured murine astrocytes, neurons and microglia in vitro. Results Oral administration of GSK1482160 significantly reduced accumulation of MC1 + and Alz50 + misfolded tau in hippocampal regions, which was accompanied with reduced accumulation of Tsg101, an exosome marker, in hippocampal neurons. Proximity ligation assay demonstrated complex formation of Alz50 + tau and Tsg101 in hippocampal neurons, which was reduced by GSK1482160. On the other hand, GSK1482160 had no effect on microglial ramification or CD68 expression, which was significantly enhanced in P301S mice, or pro/anti-inflammatory cytokine gene expression. Strikingly, GSK1482160-treated P301S mice show significantly improved working and contextual memory as determined by Y-maze and fear conditioning tests. GSK1482160 also significantly increased accumulation of Tsg101 and CD81 in microglia in vivo , suggesting its suppression of P2RX7-induced exosome secretion from microglia . This effect was confirmed in vitro, as ATP-induced secretion of tau-containing exosome was significantly suppressed by GSK1482160 treatment from primary murine microglia, but not from neurons or astrocytes. Discussion The oral administration of P2RX7 inhibition mitigates disease phenotypes in P301S mice, likely by suppressing release of microglial exosomes. P2RX7 could be a novel therapeutic target for the early stage tauopathy development.

Protection of Differentiated Neuronal Ng108-15 Cells from P2x7 Receptor-Mediated Toxicity by Taurine

Inhibition of P2X7 Receptor Ameliorates Transient Global Cerebral Ischemia/reperfusion Injury Via Modulating Inflammatory Responses in the Rat Hippocampus

Mechanisms Underlying Taurine Protection Against Glutamate-Induced Neurotoxicity

Taurine Protects R28 Cells from Hypoxia/re-Oxygenation-induced Damage Via Regulation of Mitochondrial Energy Metabolism.

Why Is Taurine Cytoprotective?

Taurine Protects Primary Neonatal Cardiomyocytes Against Apoptosis Induced By Hydrogen Peroxide

Taurine-Induced Modulation Of Voltage-Sensitive Na+ Channels In Rat Dorsal Root Ganglion Neurons

Taurine Buffers Glutamate Homeostasis in Retinal Cells in Vitro under Hypoxic Conditions.

Cytotoxicity of Malondialdehyde and Cytoprotective Effects of Taurine Via Oxidative Stress and PGC-1α Signal Pathway in C2C12 Cells

Taurine protects neuronal cells by suppressing Caspase 9 activation

Exogenous Taurine Attenuates Mitochondrial Oxidative Stress and Endoplasmic Reticulum Stress in Rat Cardiomyocytes

Neuroprotective Actions of Taurine on Hypoxic-Ischemic Brain Damage in Neonatal Rats

An Experimental Study on Lethal Effect of P2X7 Receptor Activation on Rat Retinal Ganglion Cell

Taurine attenuates methamphetamine-induced autophagy and apoptosis in PC12 cells through mTOR signaling pathway.

Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats

TonEBP modulates the protective effect of taurine in ischemia-induced cytotoxicity in cardiomyocytes

P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice

Neuroprotective Effects of Pterostilbene Against Oxidative Stress Injury: Involvement of Nuclear Factor Erythroid 2-Related Factor 2 Pathway.

Tetramethylpyrazine Analogue T-006 Protects Neuronal and Endothelial Cells Against Oxidative Stress via PI3K/AKT/mTOR and Nrf2 Signaling

Neuroprotection of Taurine Against Bilirubin-Induced Elevation of Apoptosis and Intracellular Free Calcium Ion in Vivo.

Neuroprotection Against Glutamate-Induced Excitotoxicity and Induction of Neurite Outgrowth by T-006, a Novel Multifunctional Derivative of Tetramethylpyrazine in Neuronal Cell Models.